Sophie Gobeil, Ph.D - Structural, biophysical, and biochemical studies of SARS-CoV-2 spike variants

Daniel Wrapp - Structural insights into SARS-CoV-2 S and implications for therapeutic developmentПодробнее

How spike protein discoveries drove coronavirus vaccine designПодробнее

Structure-guided design of SARS-CoV-2 subunit vaccines | David Veesler, PhDПодробнее

3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccinesПодробнее

Conférence Sophie GobeilПодробнее

SARS COV2 SPIKE PROTEIN. STRUCTURE OF COV2 SPIKE PROTEIN. ROLE OF COV2 SPIKE PROTEIN.Подробнее

Spike Protein Structure From BrisDelta, an Early SARS-CoV-2 VariantПодробнее

Structure and Design of SARS-CoV-2 SpikesПодробнее

N-glycans at N165 and N234 “lock-and-load” the open RBD for infection.Подробнее

Basic Biochemistry & Nomenclature of SARS CoV-2 Mutations & DeletionsПодробнее

Elizabeth Campbell, Virtual COVID-19 Symposium: September 23, 2020Подробнее

The Spike storyПодробнее

GlycoNet Webinar ft. Robert Woods: 3D models of glycosylated SARS-CoV-2 Spike ProteinПодробнее

SARS-CoV-2 spike prefusion structuresПодробнее

G. Papa - Role of SARS-CoV-2 Spike cleavage in virus entry and cell-cell fusionПодробнее

Dr Christopher Barnes: Structures of human antibodies bound to SARS-CoV-2 (22nd Oct 2020)Подробнее

The structure of a SARS-CoV-2 virusПодробнее

SARS-CoV-2 Spike protein ll CSIR-NET Life science ll xgene & proteinxПодробнее

Webinar: Responding to Emerging SARS CoV 2 VariantsПодробнее